Amore, Giulia
Romagnoli, Martina
Carbonelli, Michele
Barboni, Piero
Carelli, Valerio
La Morgia, Chiara http://orcid.org/0000-0002-4639-8929
Article History
First Online: 7 November 2020
Declarations
:
: No funding has been received for the preparation of this manuscript.
: VC acts as scientific consultant in boards of GenSight Biologics, Stealth BioTherapeutics, Santhera Pharmaceuticals, and Chiesi. VC received speaker honoraria from Chiesi and an unrestricted research grant from Stealth BioTherapeutics. PB, MC, VC, CLM, MR, received speaker’s honoraria and travel support from Santhera Pharmaceuticals. PB received speaker honoraria from GenSight Biologics, Visufarma and Omkron. CLM received consulting fees from Regulatory Pharmanet and Chiesi Pharmaceuticals. GA, PB, MC, VC, CLM are investigators in clinical trials from Santhera Pharmaceuticals and GenSight Biologics. MR serves as Study Coordinator in Santhera Pharmaceuticals and GenSight Biologics sponsored trials. None of these activities are in any way related to the writing of this study.
: Not applicable.
: Not applicable.
: Not applicable. No datasets were generated or analysed during the current study.
: All authors contributed to the study conception and design. Material preparation and data collection were performed by GA, MR, MC, PB and CLM. The first draft of the manuscript was written by GA, MR, VC and CLM. VC and CLM reviewed the manuscript. All authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.